Blood Sugar Control in Diabetes: Insulin's Role and Dysregulation

Diabetes mellitus is characterized by chronic hyperglycemia due to defects in insulin secretion, insulin action, or both.

Normal Glucose-Insulin Dynamics

  • Food → glucose absorption → pancreatic β-cells release insulin.
  • Insulin binds receptors → GLUT4 translocation → glucose uptake (muscle, fat, liver).
  • Insulin suppresses hepatic gluconeogenesis/glycogenolysis.
  • Result: normoglycemia (70–100 mg/dL fasting).

Pathophysiology by Type

TypePrimary DefectInsulin Level
Type 1 (T1D)Autoimmune β-cell destruction → absolute insulin deficiencyLow/absent
Type 2 (T2D)Insulin resistance + progressive β-cell failure → relative deficiencyInitially high, then declining
Gestational (GDM)Placental hormones induce insulin resistance in susceptible womenVariable
Other (MODY, LADA, pancreatic, drug-induced)Specific genetic/acquired defectsVariable

Consequences of Dysregulation

  • Acute: DKA (T1D), HHS (T2D) – medical emergencies.
  • Chronic: Microvascular (retinopathy, nephropathy, neuropathy), macrovascular (CVD, stroke), infection susceptibility.

Management Pillars

  • Glucose monitoring (CGM preferred).
  • Medications: insulin, metformin, SGLT2i, GLP-1 RA, DPP-4i, TZDs, sulfonylureas.
  • Nutrition: carb consistency/quality, Mediterranean/DASH/low-carb patterns.
  • Physical activity: 150 min/week moderate + resistance 2×/week.
  • Weight management (5–10% loss improves insulin sensitivity).
  • Cardiovascular risk reduction (statin, BP control, ASA if indicated).

Individualized, patient-centered care achieves best outcomes.

Diabetes - Related Articles